Grave Danger,” the 19th novel about Miami attorney Jack Swyteck, mixes a personal story with an international focus that ...

Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $91 which represents a slight increase of $1.06 or 1.18% from the prior close of $89.94. The stock opened at $90.59 and touched ...

There’s more than one ghost in the machine in,” Nnedi Okorafor’s new sci-fi-adjacent novel finely attuned to our age of AI ...

In “Open Socrates,” the scholar Agnes Callard argues that the ancient Greek philosopher offers a blueprint for an ethical ...

NPR's Ailsa Chang talks with Pagan Kennedy about her new book The Secret History of the Rape Kit: A True Crime Story, which ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively ...

Gilead Sciences (Gilead) is a research-based biopharmaceutical company. It carries out the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological ...

Rosie is a freelance writer living in London. She has covered everything from ancient Egyptian temples to exciting medical breakthroughs, but she particularly enjoys writing about wildlife ...

For 14 years, scientists have been growing a tree akin to the Judean balsam — the source of the balm of Gilead — but with no modern counterpart. For 14 years, scientists have been growing a ...

Gilead Sciences (GILD) closed the most recent trading day at $91.09, moving +0.44% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.09%. Elsewhere ...

Plus, news about Abili­ta Ther­a­peu­tics, Ori­on, No­var­tis, XGEN Ven­ture, Palleon, Hen­lius, TigaTx, HER­Vo­lu­tion Ther­a­peu­tics and Krys­tal Biotech: ...